China Journal of Chinese Materia Medica 2006-10-01

[Advances in studies on pharmacokinetics of aristolochic acid I].

Guan Wang, Zhi-Min Wang, Qi-Shi Sun

Index: Zhongguo Zhong Yao Za Zhi 31(19) , 1573-5, (2006)

Full Text: HTML

Abstract

Aristolochic acid I (AA-I) was absorbed and distributed quickly in vivo, the plasma concentration-time curve were fit with the open two-compartment model and one-compartment model, respectively. The elimination of AA-I has relationship with the dosage, the low dose group eliminates more quickly than the high dose group. The characters of pharmacokinetics of AA-I induce the cumulation of AA-I in vivo and the nephrotoxin to the kidney and other viscera.


Related Compounds

Related Articles:

Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.

2014-03-01

[Toxicology 318 , 22-31, (2014)]

Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.

2015-01-01

[Int. J. Mol. Sci. 16 , 16454-68, (2015)]

Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan.

2013-08-01

[Occup. Environ. Med. 70(8) , 545-51, (2013)]

Harpalycin 2 inhibits the enzymatic and platelet aggregation activities of PrTX-III, a D49 phospholipase A2 from Bothrops pirajai venom.

2012-01-01

[BMC Complement Altern. Med. 12 , 139, (2012)]

Increased expression of p21WAF1/CIP1 in kidney proximal tubules mediates fibrosis.

2015-01-15

[Am. J. Physiol. Renal Physiol. 308(2) , F122-30, (2015)]

More Articles...